2023-04-20 20:05:28
Radioembolization as a safe and effective microinvasive treatment alternative for liver cancer or liver metastases
Vienna (OTS) – In the treatment of liver tumors, it is possible to treat the patient’s disease via his blood vessels, as with a heart catheter. While the purpose of a cardiac catheter is to open vessels and protect the heart muscle, the aim of tumor embolization of the liver is to close the supplying vessels with microscopically small radioactive beads and thus destroy the malignant tissue.
This occurs because these beads emit radioactive radiation into the adjacent tissue and thus damage the tumor.
There is no radiation exposure of the skin as in the case of radiation “from outside”, but the processes in the tumor cell are comparable.
Before the actual therapy, an intervention simulation takes place: The radiologist checks access via the tumor vessels.
“The nuclear medicine doctor recognizes any peculiarities in the vascular supply in the upper abdomen or in the direction of the lungs and individually calculates the exact therapy dose, which makes this embolization method unique,” explains OA. Dr. Georg Gotschuli, Nuclear physician at the State Hospital Hochsteiermark – Leoben site and member of the advisory board of the Austrian Society for Nuclear Medicine and Molecular Imaging, OGNMB.
The treatment is generally well tolerated and has few complications. The quality of life is significantly better and fewer occur following treatment flu-like symptoms such as nausea, fever, body aches and abdominal pain.
After the therapy, the patients remain on the ward for one night for observation.
In Austria, the Radioembolization performed in liver cancer and liver metastases:
- Linz, Nuclear medicine in the Linz Order Clinic, Barmh. Nurses – Prim. Joseph Dierneder
- Salzburg, University Clinic for Nuclear Medicine – Dr. Gregor Schweighofer-Zwink
- St. Polten, University Hospital, Clinical Institute for Nuclear Medicine – Prim. Prof. Dr. Anton Staudenherz
- Feldkirch, Academic Teaching Hospital, Dept. for Nuclear Medicine – Prim. Univ.-Doz. dr Alexander Becherer
Questions & contact:
Dr. Britta Fischill
Fischill PR
+43 676 3039699
britta@fischill.at
1682040691
#OGNMB #Nuclear #medicine #method #liver #cancer #OGNMB
